Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Levrero

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Nature Communications|February 1, 2020
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infectionValeria Barili, Paola Fisicaro, Barbara Montanini, et al.
Gut|May 2, 2024
TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanismArmando Andres Roca Suarez, Marie-Laure Plissonnier, Xavier Grand, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 17, 2023
Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived OrganoidsMario Cioce, Maria Rita Fumagalli, Sara Donzelli, et al.
The Lancet. Gastroenterology & Hepatology|September 21, 2024
Availability of point-of-care HBV tests in resource-limited settingsDaryl T Y Lau, Kathy Jackson, Camila A Picchio, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 1, 2011
Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian WorkshopGiampiero Carosi, Mario Rizzetto, Alfredo Alberti, et al.
Gut|February 12, 2015
Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cureMirjam B Zeisel, Julie Lucifora, William S Mason, et al.
JHEP Reports : Innovation in Hepatology|September 18, 2024
HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBxMarc Ringelhan, Svenja Schuehle, Maarten van de Klundert, et al.
Viruses|February 28, 2020
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in VitroRomina Salpini, Lorenzo Piermatteo, Arianna Battisti, et al.
Journal of Hepatology|August 22, 2008
Statements from the Taormina expert meeting on occult hepatitis B virus infectionGiovanni Raimondo, Jean-Pierre Allain, Maurizia R Brunetto, et al.
Journal of Hepatology|February 29, 2024
Single-cell landscape of functionally cured chronic hepatitis B patients reveals activation of innate and altered CD4-CTL-driven adaptive immunityBalakrishnan Chakrapani Narmada, Atefeh Khakpoor, Niranjan Shirgaonkar, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Nature Communications|February 1, 2020
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infectionValeria Barili, Paola Fisicaro, Barbara Montanini, et al.
Gut|May 2, 2024
TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanismArmando Andres Roca Suarez, Marie-Laure Plissonnier, Xavier Grand, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 17, 2023
Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived OrganoidsMario Cioce, Maria Rita Fumagalli, Sara Donzelli, et al.
The Lancet. Gastroenterology & Hepatology|September 21, 2024
Availability of point-of-care HBV tests in resource-limited settingsDaryl T Y Lau, Kathy Jackson, Camila A Picchio, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 1, 2011
Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian WorkshopGiampiero Carosi, Mario Rizzetto, Alfredo Alberti, et al.
Gut|February 12, 2015
Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cureMirjam B Zeisel, Julie Lucifora, William S Mason, et al.
JHEP Reports : Innovation in Hepatology|September 18, 2024
HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBxMarc Ringelhan, Svenja Schuehle, Maarten van de Klundert, et al.
Viruses|February 28, 2020
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in VitroRomina Salpini, Lorenzo Piermatteo, Arianna Battisti, et al.
Journal of Hepatology|August 22, 2008
Statements from the Taormina expert meeting on occult hepatitis B virus infectionGiovanni Raimondo, Jean-Pierre Allain, Maurizia R Brunetto, et al.
Journal of Hepatology|February 29, 2024
Single-cell landscape of functionally cured chronic hepatitis B patients reveals activation of innate and altered CD4-CTL-driven adaptive immunityBalakrishnan Chakrapani Narmada, Atefeh Khakpoor, Niranjan Shirgaonkar, et al.
Pageof 14